Despite its widespread use in IBD diagnosis, CRP is upregulated in the case of autoimmune disorders, infections, cardiovascular diseases, diabetes as well as malignancies (Liu et al. 2022). This evidence concerns the gene CRP and inflammatory bowel disease.